{
    "2019-05-06": [
        [
            {
                "time": "2018-05-06",
                "original_text": "Top Ranked Income Stocks to Buy for May 6th",
                "features": {
                    "keywords": [
                        "Ranked",
                        "Income",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-06",
                "original_text": "The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Merck",
                        "Pfizer",
                        "AbbVie",
                        "Sanofi",
                        "Glaxo"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-06",
                "original_text": "Two Healthcare Stocks in the XLV Fund Stand Out",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "XLV",
                        "Fund",
                        "Stand",
                        "Out"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-06",
                "original_text": "Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002",
                "features": {
                    "keywords": [
                        "Alector",
                        "Alzheimer’s",
                        "Disease",
                        "Patient",
                        "Phase",
                        "1b",
                        "Study",
                        "AL002"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}